With Lenti­Glo­bin cleared by FDA, blue­bird lifts EU mar­ket­ing hold on gene ther­a­py us­ing the same de­liv­ery mech­a­nism

4 years ago
Cell/Gene Tx

Pelosi threat­ens to slide drug pric­ing re­form in­to Biden's bud­get bill, re­jects in­dus­try push­back that in­no­va­tion ...

4 years ago
Pharma

As Pfiz­er/BioN­Tech prep EUA fil­ing for Covid-19 boost­er, FDA, CDC tell Amer­i­cans they don't need one just yet

4 years ago
FDA+
Coronavirus

Ovid shuf­fles C-suite, lays off staff in wake of PhI­II An­gel­man syn­drome fail

4 years ago
People
R&D

Kick­ing the habit, Philip Mor­ris forges $1.5B deal to ac­quire Vec­tura in race to build a top in­haled-drug com­pa­ny

4 years ago
Deals

No­vo Seeds launch­es a new neu­ro biotech as Alzheimer's R&D booms

4 years ago
Financing

Of­ten-passed plant in Col­orado has a new own­er, who's al­ready op­er­at­ing near­by

4 years ago
R&D
Manufacturing

Mo­roc­can gov­ern­ment drops $500M in­to new Re­ci­pharm fill-fin­ish plant in big boost for African man­u­fac­tur­ing

4 years ago
Outsourcing
Manufacturing

Re­call re­port: Teva's chemother­a­py drug re­called af­ter in­ves­ti­ga­tors find par­tic­u­lates in­side vials

4 years ago
Manufacturing

Agenus to move Cal­i­for­nia op­er­a­tions to new bio­man­u­fac­tur­ing clus­ter in Va­cav­ille

4 years ago
Manufacturing

FDA hands a warn­ing let­ter to a Lupin sub­sidiary af­ter fail­ing to main­tain clean­li­ness once again

4 years ago
Outsourcing
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: In a push to vac­ci­nate Asia, South Ko­rea ready to make 1B vac­cine avail­able; Mex­i­co's ...

4 years ago
Coronavirus
Manufacturing

BioN­Tech and Takara en­ter li­cense agree­ment for CAR-T; The FDA has freed an­oth­er batch of J&J's Covid-19 vac­cine

4 years ago
Manufacturing

Bridge­Bio adds 3 more in­sti­tu­tions to its ros­ter of col­lab­o­ra­tors; Ex­sci­en­tia lands Gates Foun­da­tion mon­ey for ...

4 years ago
News Briefing

As­traZeneca takes a chance on the STING path­way with F-star

4 years ago
Deals

HHS with­draws Trump-era plan to al­low more per­son­al drug, in­sulin im­ports

4 years ago
FDA+

J&J, Sid Mukher­jee's Vor team up to pair bis­pecifics with en­gi­neered stem cells for blood can­cer

4 years ago
Deals
R&D

A bright fu­ture for LAG-3? Top an­a­lysts see an arms race in the mak­ing, but drug­mak­ers need a bi­ol­o­gy break­through

4 years ago
R&D

Bio­gen nar­rows its Aduhelm la­bel af­ter FDA left the flood­gates open

4 years ago
Pharma
FDA+

A Mubadala-backed biotech is us­ing pa­tient tu­mor tis­sue grown in a petri dish to change pre­ci­sion on­col­o­gy

4 years ago
Financing
AI

In pur­suit of a block­buster, Am­gen and As­traZeneca score pri­or­i­ty re­view for asth­ma drug teze­pelum­ab

4 years ago
FDA+

On­copep­tides says a sec­ond look at its da­ta of­fers a win in head-to-head can­cer tri­al — but key OS flop trig­gers a ...

4 years ago
R&D
FDA+

A uni­corn built on lies? Founders of Sanofi part­ner may face 20 years in prison for al­leged­ly prof­it­ing from stolen ...

4 years ago
People

Eli Lil­ly makes mod­est bet on 'all-in-hu­man' dis­cov­ery out­fit for ALS drugs, deep­en­ing bid in pre­ci­sion neu­rol­o­gy

4 years ago
Deals
First page Previous page 669670671672673674675 Next page Last page
A service from the Financial Times